Skip to content
healthcare.dev

Cytogam

NDC 49591-532, HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN, liquid, from Kamada Ltd..

Product NDC
49591-532
Status
Listed
Labeler
Kamada Ltd.
Dosage form
LIQUID
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA103189
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49591-532 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN2500 mg/50mL

Pharmacologic classes

Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]; Virus Neutralization [MoA]; Virus-specific Hyperimmune Globulins [EXT]

Package NDCNDC-11Package
49591-532-51495910532511 VIAL, GLASS in 1 CARTON (49591-532-51) / 50 mL in 1 VIAL, GLASS (49591-532-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=49591-532

Use it

Look up 49591-532 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49591-532 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49591-532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.